Nasdaq GlobeNewswire

Palo Alto startup 8th Wall launches cross-platform tools for Mobile AR

Del

8th Wall XR provides a single solution for developing AR apps on all iOS and Android phones

PALO ALTO, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- 8th Wall, Inc. announced today 8th Wall XR, the world's first Augmented Reality (AR) platform that works on all commonly available iOS and Android phones and integrates seamlessly with ARKit (Apple) and Tango (Google).

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/51163dc6-2e25-4f8d-a653-d797786f1e26

Founded in August 2016, 8th Wall is a Palo Alto startup made up of an all-star team of ex-Google and Facebook engineers with extensive experience in computer vision, machine learning and product development. Passionate about AR, the team believes that the shift to widespread AR adoption will start with today's mobile phones. As a result they have been working on a suite of native tools that make it effortless to develop AR applications for mobile.

Even with promising native AR frameworks such as ARKit becoming available later this year, current estimates put the availability of native mobile AR frameworks at less than 15% of smartphones in 2018. This severely limits the consumer reach of these applications compared to standard mobile apps.

In contrast, 8th Wall XR provides a cross-platform AR solution that works on any common phone with or without native AR frameworks, proving an estimated 650% increase in the number of supported smartphones. When a phone supports a native framework such as ARKit or Tango, 8th Wall XR uses these libraries to provide 6 Degrees-of-Freedom (DoF) tracking, surface estimation, lighting estimation, and calibrated scene display. For other phones, 8th Wall XR provides 3DoF tracking, fixed surfaces, camera calibration information and vision-based lighting estimation. Later this year the team plans to bring 6 DoF to all supported phones as well, using 8th Wall's vision and machine learning algorithms.

"8th Wall XR works by bringing the best possible AR experience to each user's device," said Erik Murphy-Chutorian, Founder and CEO of 8th Wall. "It leverages native libraries like ARKit or Tango when available, and in their absence as is common today, the very same apps run on all other iOS or Android devices by using the phone's camera and inertial sensors. We've made it much faster to develop as well, addressing the current shortcomings and challenges in building an AR app today. With 8th Wall XR, developers can now effortlessly create an AR application in a matter of minutes."

Beginning today, 8th Wall XR is publicly available to Unity developers at www.8thwall.com and is also available as a native library for iOS and Android per arrangement.  The team plans to support additional platforms in the future.

About 8th Wall, Inc.

8th Wall's mission is to break the wall between the digital world and the physical world by creating software that enables developers to quickly and easily build mobile applications that interact with the real world. The 8th Wall team is comprised of proven experts with deep expertise in computer vision, image infrastructure, machine learning and full-stack mobile product development. For more information, please visit www.8thwall.com

Trademarks

8th Wall, 8th Wall, Inc., 8th Wall XR and associated logos are registered trademarks or trademarks of 8th Wall, Inc. and/or its affiliates in the United States and/or other countries. All other trademarks are the property of their respective owners.

Safe Harbor

The preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functionality described for 8th Wall's products remain at the sole discretion of 8th Wall, Inc.

Dana Elizabeth
dana@8thwall.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: 8th Wall via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

GlobeNewswire Test Release26.5.2018 07:00Pressemelding

LOS ANGELES, May 25, 2018 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING – -END- CONTACT: Karen Yu Director, GlobeNewswire Product Management Direct: +1 310 258 6917 Mobile: +1 626 389 7427 or Magali Rolandez Senior Manager, Media Relations/Content Distribution Europe Direct: +44 (0) 203 753 2215 Mobile: +44 (0) 7785 619 539

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering25.5.2018 16:38Pressemelding

Jacobs, one of the world's largest engineering and environmental consultancy groups, has more than 70,000 employees globally SYDNEY, Australia and MINNEAPOLIS, May 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio's Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions. Through the Mental Health Check-In, companies can offer employees an end-to-end mental health program, direct to their devices, to see how the mind and body are tracking. It's a personalized, private, and objective way to see the unseeable: mental health issues in the workplace. Employees are provided the opportunity to confidentially check-in on their mental health and receive personalized confidential results from both an objective biometric screening in conjunction with a 12-minute subjective survey. Employers receive

VIRGIN PULSE ANNOUNCES INDUSTRY-LEADING GDPR COMPLIANCE25.5.2018 14:00Pressemelding

Virgin Pulse Extends the GDPR's Strong Data Privacy Rights to All Clients and Members Across the Globe PROVIDENCE, R.I., May 25, 2018 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of digital employee health, wellbeing and engagement solutions, today announced that it has achieved compliance with the EU General Data Protection Regulation (GDPR) for the Virgin Pulse platform. The company has also appointed Associate Counsel Beatrice Botti as Data Protection Officer (DPO) to oversee the Virgin Pulse privacy program. With this achievement, Virgin Pulse leads the market as the first company in the wellbeing and engagement industry to fully meet the comprehensive standards of the new GDPR data privacy law. The company has completed a thorough review of its internal data collection, storage and handling processes and implemented enhancements to achieve GDPR compliance and give all Virgin Pulse customers and members greater control over their personal data. The GDPR is the firs

Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45Pressemelding

CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressemelding

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressemelding

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom